LONG MINI-FUTURE - MERCK & CO. Share Price

Certificat

DE000VM543E1

Delayed Deutsche Boerse AG 19:04:27 25/06/2024 BST
3.7 EUR +2.21% Intraday chart for LONG MINI-FUTURE - MERCK & CO.
Current month+25.00%
1 month+9.79%
Date Price Change
25/06/24 3.7 +2.21%
24/06/24 3.62 +6.47%
21/06/24 3.4 -1.16%
20/06/24 3.44 +9.21%
19/06/24 3.15 -2.78%

Delayed Quote Deutsche Boerse AG

Last update June 25, 2024 at 07:04 pm

More quotes

Static data

Product typeKnock-Out con Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM543E
ISINDE000VM543E1
Date issued 29/11/2023
Strike 93.71 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.95
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 3.74
Lowest since issue 0.95
Spread 0.08
Spread %2.14%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
132.9 USD
Average target price
142.7 USD
Spread / Average Target
+7.34%
Consensus